Overview and Scope
Tumor embolization devices are minimally invasive devices used in the treatment of tumors. These devices are used either to shut down the supply of blood to the tumor or to deliver tumor-killing therapy directly to the tumor.
Sizing and Forecast
The tumor embolization devices market size has grown rapidly in recent years. It will grow from <b>$1.62 billion in 2023 to $1.82 billion in 2024 at a compound annual growth rate (CAGR) of 12.8%. </b> The growth in the historic period can be attributed to minimally invasive procedures, technological advancements, cancer incidence, aging population.
The tumor embolization devices market size is expected to see rapid growth in the next few years. It will grow to <b>$2.83 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. </b> The growth in the forecast period can be attributed to personalized medicine, combination therapies, image-guided embolization, telemedicine and remote consultations. Major trends in the forecast period include innovations in embolic agents, transarterial chemoembolization (tace), embolization for palliative care, image-guided procedures.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
Segmentation & Regional Insights
The tumor embolization devices market covered in this report is segmented –
1) By Type: Radioembolic Agents, Non-radioactive Embolic Agents
2) By Application: Cancer Tumors, Noncancerous Tumors
3) By End User: Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers
<b>North America</b> was the largest region in the tumor embolization devices market in 2023. <b>Asia-Pacific</b> was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3352&type=smp
Major Driver Impacting Market Growth
The rise in the number of cancer cases across the globe is likely to contribute to the growth of the tumor embolization devices market during the forecast period. According to the American Cancer Society, there were about 1.9 million new cases and 608,570 cancer deaths in 2021 in the USA. The four most common types of cancers worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of all new cancer cases. Therefore, the rise in the cancer incidence rate globally is anticipated to boost the demand for the tumor embolization market over the forthcoming years.
Key Industry Players
Major companies operating in the tumor embolization devices market include <b>Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Siemens Healthineers AG, Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Imagion Biosystems Ltd., Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Monteris Medical Corporation, NeuWave Medical Inc., Neoprobe Corporation, OncoSec Medical Incorporated, Helomics Corporation, Hologic, Surefire Medical Inc., Varian Medical Systems Inc.</b>
The tumor embolization devices market report table of contents includes:
1. Executive Summary
2. Tumor Embolization Devices Market Characteristics
3. Tumor Embolization Devices Market Trends And Strategies
4. Tumor Embolization Devices Market – Macro Economic Scenario
5. Global Tumor Embolization Devices Market Size and Growth
.
.
.
26. South America Tumor Embolization Devices Market
27. Brazil Tumor Embolization Devices Market
28. Middle East Tumor Embolization Devices Market
29. Africa Tumor Embolization Devices Market
30. Tumor Embolization Devices Market Competitive Landscape And Company Profiles
Top Major Players:
- Boston Scientific Corporation
- Medtronic PLC
- Terumo Corporation
- Sirtex Medical Limited
- Merit Medical Systems In
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
